60
Participants
Start Date
September 30, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
November 30, 2026
Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1
Subjects will receive daily noninvasive ultrasound stimulation of the spleen using Ultrasound Treatment Setting 1 for 20 minutes once per day
Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2
Subjects will receive daily noninvasive ultrasound stimulation of the spleen using Ultrasound Treatment Setting 2 for 20 minutes once per day
Sham ultrasound stimulation (control)
Sham ultrasound stimulation for 20 minutes once per day
Conventional Synthetic DMARD
All subjects will take at least one type of conventional synthetic DMARD at the same stable dose for at least 8 weeks prior to the treatment period and continuing through study close out
RECRUITING
University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases, Minneapolis
SecondWave Systems Inc.
INDUSTRY